Shen et al. [31] reported that MDM2-mediated ubiquitination of ACE2 contributed to the development of PAH, and the MDM2 inhibitor JNJ-165 reversed SU5416/hypoxia-induced PAH in mice model. This evidence concerns the gene ACE2 and pulmonary arterial hypertension.